跳至主要内容
临床试验/NCT03203980
NCT03203980Unknown不适用

Bleeding Events After Triple Antithrombotic Therapy Initiation: a Prospective Observational Study in Real Life

Central Hospital, Nancy, France0 个研究点目标入组 200 人开始时间: 2017年7月15日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
200
主要终点
Bleeding events

研究概览

简要总结

The optimal antithrombotic therapy for patients requiring anticoagulation after coronary stenting is unknown. Double platelets suppressive agents combined with oral anticoagulation (triple antithrombotic therapy) remains the Gold standard.

Our study aims at studying bleeding events occurring until 6 months after the initiation of triple antithrombotic therapy.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients requiring triple antithrombotic therapy, including double antiplatelets agents and oral anticoagulation

排除标准

  • history of bleeding
  • patients already under triple antithrombotic therapy
  • patients under vitamin K antagonists

结局指标

主要结局

Bleeding events

时间窗: within 6 months since the initiation of triple antithrombotic therapy

Bleeding events with clinical significance

次要结局

未报告次要终点

研究者

发起方
Central Hospital, Nancy, France
申办方类型
Other
责任方
Sponsor

相似试验